Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Keith Wilson

7PUBLICATIONS

66CO-AUTHORS

Respiratory diseasesPredictive and prognostic markersGene and molecular therapyHaematological tumoursRegenerative medicine (incl. stem cells)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Mar 07, 2026

Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study.

Malgorzata Mikulska, Gloria Tridello, Per Ljungman

|Jul 23, 2024

Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.

Anne Mea Spanjaart, Per Ljungman, Gloria Tridello

|May 13, 2024

Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT.

Marie Robin, Simona Iacobelli, Linda Koster

|Mar 16, 2024

Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT.

Marie Robin, Simona Iacobelli, Linda Koster

|Jan 10, 2024

Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.

Mitja Nabergoj, Diderik-Jan Eikema, Linda Koster

|Dec 01, 2023

Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party.

Jesús Duque-Afonso, Jürgen Finke, Maud Ngoya

Pageof 2

Frequent Collaborators

4 joint publications

Kavita Raj

3 joint publications

Jürgen Finke

3 joint publications

Edouard Forcade

3 joint publications

Donal P McLornan

3 joint publications

Marie Robin

3 joint publications

John A Snowden

3 joint publications

Joanna Drozd-Sokolowska

3 joint publications

Nicolaus Kröger

2 joint publications

Emma Nicholson

2 joint publications

Arnon Nagler

Frequent Collaborators

4 joint publications

Kavita Raj

3 joint publications

Jürgen Finke

3 joint publications

Edouard Forcade

3 joint publications

Donal P McLornan

Top Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on : Apr 01, 2015

See more related videos

Top Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on : Apr 01, 2015

See more related videos